期刊
ONCOIMMUNOLOGY
卷 1, 期 4, 页码 -出版社
LANDES BIOSCIENCE
DOI: 10.4161/onci.19406
关键词
cancer; NKG2D ligand; ULBP2; miR-34; p53
The activating receptor NKG2D, expressed on different innate and adaptive cytotoxic lymphocytes, has been demonstrated to play an important role in anti-tumor immunity. Now evidence is provided that tumor suppressors control expression of its ligand ULBP2 supporting the role of this receptor-ligand system as an innate barrier against tumor development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据